Target intelligence / Profile preview

Amino acid transporter

Molecular classification
Transporter, Solute carrier (SLC) family, Membrane protein
01

Overview

The phrase "Nutritional support via direct absorption of free amino acids" does not refer to a single molecular target but rather describes a **physiological process** mediated by a diverse group of membrane proteins known as **amino acid transporters**. These are primarily members of the solute carrier (SLC) superfamily that facilitate the uptake and distribution of dietary or circulating free amino acids across cell membranes—most notably in intestinal epithelial cells during digestion and absorption. There are multiple families within this group—including neutral, cationic, acidic, branched-chain-specific transporters—each with distinct substrate preferences and tissue distributions. Their coordinated activity is essential for maintaining plasma amino acid homeostasis and supporting cellular metabolism throughout the body. Amino acid transporters play critical roles beyond nutrition; they participate in neurotransmission, immune function, energy metabolism, mTOR signaling regulation, autophagy control, insulin secretion modulation—and their dysregulation is implicated in various diseases such as inherited metabolic disorders (e.g., cystinuria), cancers (where certain SLCs like LAT1/SLC7A5 are upregulated), diabetes mellitus/obesity-related pathologies due to altered nutrient sensing/metabolism. While no clinical therapies currently target these proteins specifically for nutritional support purposes, they remain an area of active investigation both as potential drug targets—especially in oncology—and as biomarkers. Because "Nutritional support via direct absorption of free amino acids" is not itself a molecule or receptor but rather describes a biological process involving many related proteins, it should not be considered a canonical therapeutic target name. The correct approach would be to specify individual **amino acid transporter** subtypes such as "Neutral amino acid transporter ASCT2 (SLC1A5)" or "Cationic amino acid transporter 1 (SLC7A1)" depending on context. Therefore: is_incorrect: true — This entry refers to a physiological process involving multiple molecular entities rather than one defined therapeutic target.

Other names
Amino acid transport proteinSolute carrier (SLC) family transporterNeutral amino acid transporterCationic amino acid transporterSystem A/N/L transporters
02

Mechanism of action

Facilitate or mediate the transmembrane movement of free amino acids via symport or antiport mechanisms

03

Biological functions

Nutrient absorptionCellular uptake of amino acidsRegulation of intracellular amino acid levelsMetabolic homeostasis
04

Disease associations

Inborn errors of metabolism (e.g., cystinuria, Hartnup disorder)Cancer (metabolic reprogramming)Diabetes and obesity (altered nutrient sensing/metabolism)Other metabolic diseases
05

Safety considerations

Broad inhibition can disrupt essential nutrient uptake and cause systemic toxicity
06

Interacting drugs

No approved drugs directly targeting these transporters for nutritional support; some experimental inhibitors exist for specific SLCs in cancer research
07

Biomarkers

Expression levels of specific SLC family members in tissues may serve as biomarkers in cancer and metabolic disease research

Beyond the preview

Go deeper on Amino acid transporter.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Amino acid transporter.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call